Filing Details
- Accession Number:
- 0001225208-18-002314
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-08 16:14:55
- Reporting Period:
- 2018-02-07
- Accepted Time:
- 2018-02-08 16:14:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1484186 | Michael Joseph Fitzgerald | 300 Boston Scientific Way Marlborough MA 01752-1234 | Evp & President, Rhythm Mgmt | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-02-07 | 85,227 | $12.52 | 237,152 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-02-07 | 85,227 | $26.48 | 151,925 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2018-02-07 | 85,227 | $0.00 | 85,227 | $12.52 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2018-02-12 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 77,323 | Indirect | By 401(k) |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
- Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $26.39 to $26.57, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
- Grant to the reporting person of an option to purchase 85,227 shares of common stock vesting in four annual increments beginning on February 12, 2009, the first anniversary of the grant.